TY - JOUR AU - Abi-Ghanem, A. S. PY - 2015 DA - 2015// TI - Radionuclide therapy for osseous metastases in prostate cancer JO - Semin Nucl Med VL - 45 UR - https://doi.org/10.1053/j.semnuclmed.2014.07.006 DO - 10.1053/j.semnuclmed.2014.07.006 ID - Abi-Ghanem2015 ER - TY - BOOK AU - Balaji, K. C. PY - 2016 DA - 2016// TI - Managing metastatic prostate Cancer in your urological oncology practice PB - Springer International Publishing CY - Switzerland UR - https://doi.org/10.1007/978-3-319-31341-2 DO - 10.1007/978-3-319-31341-2 ID - Balaji2016 ER - TY - BOOK AU - Bem, A. AU - Michalski, G. PY - 2015 DA - 2015// TI - Hospital profitability vs. selected healthcare system indicators. Central European conference in finance and economics PB - Technical University CY - Košice ID - Bem2015 ER - TY - JOUR AU - Buroni, F. E. PY - 2016 DA - 2016// TI - Radium-223: insight and perspectives in bone-metastatic Castrational-resistant prostate Cancer JO - Anticancer Res VL - 36 UR - https://doi.org/10.21873/anticanres.11155 DO - 10.21873/anticanres.11155 ID - Buroni2016 ER - TY - JOUR AU - Ciani, O. PY - 2017 DA - 2017// TI - Linking the regulatory and reimbursement processes for medical devices: the need for integrated assessments JO - Health Econ VL - 26 UR - https://doi.org/10.1002/hec.3479 DO - 10.1002/hec.3479 ID - Ciani2017 ER - TY - JOUR AU - Deshayes, E. PY - 2017 DA - 2017// TI - Radium 223 dichloride for prostate cancer treatment. Drug design JO - Development and therapy VL - 11 UR - https://doi.org/10.2147/DDDT.S122417 DO - 10.2147/DDDT.S122417 ID - Deshayes2017 ER - TY - JOUR AU - Du, Y. PY - 2017 DA - 2017// TI - Practical recommendations for radium-223 treatment of metastatic castration-resistant prostate cancer JO - Eur J Nucl Med Mol Imaging VL - 44 UR - https://doi.org/10.1007/s00259-017-3756-7 DO - 10.1007/s00259-017-3756-7 ID - Du2017 ER - TY - JOUR AU - Ehlers, L. AU - Vestergaard, M. AU - Kidholm, K. PY - 2006 DA - 2006// TI - Doing mini-health technology assessments in hospitals: a new concept of decision support in health care? JO - Int J Technol Assess Health Care VL - 22 UR - https://doi.org/10.1017/S0266462306051178 DO - 10.1017/S0266462306051178 ID - Ehlers2006 ER - TY - STD TI - EUnetHTA Joint Action 2, HTA Core Model for Rapid Relative Effectiveness, Final Version 4.2. November 2015. http://meka.thl.fi/htacore/model/HTACoreModel_ForRapidREAs4.2.pdf. Accessed 26 June 2018. UR - http://meka.thl.fi/htacore/model/HTACoreModel_ForRapidREAs4.2.pdf ID - ref9 ER - TY - STD TI - EUnetHTA Joint Action 2, Work Package 8. HTA Core Model ® version 3.0 (Pdf); 2016. https://meka.thl.fi/htacore/BrowseModel.aspx. Accessed 15 Dec 2017. UR - https://meka.thl.fi/htacore/BrowseModel.aspx ID - ref10 ER - TY - JOUR AU - Fuchs, S. AU - Olberg, B. AU - Panteli, D. AU - Perleth, M. AU - Busse, R. PY - 2017 DA - 2017// TI - HTA of medical devices: challenges and ideas for the future from a European perspective JO - Health Policy VL - 121 UR - https://doi.org/10.1016/j.healthpol.2016.08.010 DO - 10.1016/j.healthpol.2016.08.010 ID - Fuchs2017 ER - TY - JOUR AU - Gavurová, B. PY - 2017 DA - 2017// TI - Similarity of Slovak regions in neoplastic mortality in the context of risk factors and access to health care JO - Cent Eur J Public Health VL - 25 UR - https://doi.org/10.21101/cejph.a5051 DO - 10.21101/cejph.a5051 ID - Gavurová2017 ER - TY - BOOK AU - Goodman, C. S. PY - 2014 DA - 2014// TI - HTA101. Introduction to health technology assessment PB - USA National Library of Medicine CY - Bethesda (MD) ID - Goodman2014 ER - TY - STD TI - HTAi. HTA Glossary. 2012. http://htaglossary.net/HomePage. Accessed 8 June 2018. UR - http://htaglossary.net/HomePage ID - ref14 ER - TY - JOUR AU - Ivlev, I. AU - Kneppo, P. AU - Barták, M. PY - 2015 DA - 2015// TI - Method for selecting expert groups and determining the importance of experts' judgments for the purpose of managerial decision-making tasks in health system. E+M Ekonomie a JO - Management VL - 18 ID - Ivlev2015 ER - TY - STD TI - Kanters TA, Hakkaart L, Rutten-van Mölken M, Redekop K. Access to orphan drugs in western Europe: can more systematic policymaking really help to avoid different decisions about the same drug? Expert Rev Pharmacoecon Outcomes Res. 2015:1–3. ID - ref16 ER - TY - JOUR AU - Katolická, J. PY - 2017 DA - 2017// TI - Pokročilý metastatický kastračně rezistentní karcinom prostaty (mCRPC) v souladu s léčbou ARTA (androgen receptor axis target therapy) a radia 223 JO - Onkologie VL - 11 ID - Katolická2017 ER - TY - JOUR AU - Kristensen, F. B. PY - 2017 DA - 2017// TI - The HTA Core model ®- 10 years of developing an international framework to share multidimensional value assessment JO - Value Health VL - 20 UR - https://doi.org/10.1016/j.jval.2016.12.010 DO - 10.1016/j.jval.2016.12.010 ID - Kristensen2017 ER - TY - JOUR AU - Lien, L. M. PY - 2015 DA - 2015// TI - Treatment of castration-resistant prostate cancer and bone metastases with radium-223 dichloride JO - Int J Urol Nurs VL - 9 UR - https://doi.org/10.1111/ijun.12059 DO - 10.1111/ijun.12059 ID - Lien2015 ER - TY - JOUR AU - Löblová, O. l. g. a. PY - 2017 DA - 2017// TI - What has health technology assessment ever done for us? JO - Journal of Health Services Research & Policy VL - 23 UR - https://doi.org/10.1177/1355819617725545 DO - 10.1177/1355819617725545 ID - Löblová2017 ER - TY - JOUR AU - Löblová, O. PY - 2016 DA - 2016// TI - Three worlds of health technology assessment: explaining patterns of diffusion of HTA agencies in Europe JO - Health Economics, Policy and Law VL - 11 UR - https://doi.org/10.1017/S1744133115000444 DO - 10.1017/S1744133115000444 ID - Löblová2016 ER - TY - JOUR AU - Marenčák, J. PY - 2015 DA - 2015// TI - Súčasné možnosti sekvenčnej liečby kastračne rezistentného karcinómu prostaty JO - Farmakoterapia VL - 5 ID - Marenčák2015 ER - TY - STD TI - Medicines for Europe. Value added medicines: time to adjust the HTA decision frameworks, 2017. http://www.medicinesforeurope.com/wp-content/uploads/2017/09/White-paper_HTAonValueaddedmedicines_Final.pdf. Accessed 13 Feb 2018. UR - http://www.medicinesforeurope.com/wp-content/uploads/2017/09/White-paper_HTAonValueaddedmedicines_Final.pdf ID - ref23 ER - TY - JOUR AU - Norum, J. PY - 2015 DA - 2015// TI - Health economics and Radium-223 (Xofigo ®) in the treatment of metastatic castration-resistant prostate Cancer (mCRPC): a case history and a systematic review of the literature JO - Global J Health Sci VL - 8 UR - https://doi.org/10.5539/gjhs.v8n4p1 DO - 10.5539/gjhs.v8n4p1 ID - Norum2015 ER - TY - JOUR AU - Parker, C. PY - 2013 DA - 2013// TI - Alpha emitter radium-223 and survival in metastatic prostate cancer JO - N Engl J Med VL - 396 UR - https://doi.org/10.1056/NEJMoa1213755 DO - 10.1056/NEJMoa1213755 ID - Parker2013 ER - TY - JOUR AU - Parker, C. PY - 2016 DA - 2016// TI - Efficacy and safety of Radium-223 dichloride in symptomatic castration-resistant prostate Cancer patients with or without baseline opioid use from the phase 3 ALSYMPCA trial JO - Eur Urol VL - 70 UR - https://doi.org/10.1016/j.eururo.2016.06.002 DO - 10.1016/j.eururo.2016.06.002 ID - Parker2016 ER - TY - JOUR AU - Paulden, M. AU - Culyer, A. J. AU - O’Mahony, J. F. AU - McCabe, C. PY - 2014 DA - 2014// TI - Some inconsistencies in NICE’s consideration of social values JO - PharmacoEconomics VL - 32 UR - https://doi.org/10.1007/s40273-014-0204-4 DO - 10.1007/s40273-014-0204-4 ID - Paulden2014 ER - TY - JOUR AU - Poláček, H. PY - 2016 DA - 2016// TI - Rádium 223Ra v liečbe malígnych nádorov kostí JO - Onkológia VL - 11 ID - Poláček2016 ER - TY - JOUR AU - Rogalewicz, V. PY - 2015 DA - 2015// TI - Health technology assessment (HTA): zdroj podpůrných informací pro strategické rozhodování JO - Ekonomie ve zdravotnictví VL - 1 ID - Rogalewicz2015 ER - TY - CHAP AU - Rogalewicz, V. AU - Barták, M. PY - 2017 DA - 2017// TI - QALYs and cost-effectiveness thresholds: critical reflections BT - Central European conference in finance and economics (CEFE2017) PB - Technická univerzita v Košiciach, Ekonomická fakulta CY - Košice ID - Rogalewicz2017 ER - TY - STD TI - Rogalewicz V, Kubátová I, Donin G, Doležal T, Lamblová K, Bartáková J, Kneppo P. HTA in the Czech Republic: Still Behind. In: World Congress on Medical Physics and Biomedical Engineering 2018 (Vol. 2). Springer Nature Singapore Pte Ltd., 2019. pp. 101–105. IFMBE Proceedings. vol. 68/2. ISSN 1680–0737. ID - ref31 ER - TY - JOUR AU - Saad, F. PY - 2016 DA - 2016// TI - Radium-223 and concomitant therapies in patients with metastatic castration-resistant prostate cancer: an international, early access, open-label, single-arm phase 3b trial JO - The Lancet Oncology VL - 17 UR - https://doi.org/10.1016/S1470-2045(16)30173-5 DO - 10.1016/S1470-2045(16)30173-5 ID - Saad2016 ER - TY - JOUR AU - Sandman, L. AU - Gustavsson, E. PY - 2016 DA - 2016// TI - Beyond the black box approach to ethics! JO - International Journal of Health Policy and Management VL - 5 UR - https://doi.org/10.15171/ijhpm.2016.43 DO - 10.15171/ijhpm.2016.43 ID - Sandman2016 ER - TY - JOUR AU - Sartor, O. PY - 2016 DA - 2016// TI - Chemotherapy following radium-223 dichloride treatment in ALSYMPCA JO - Prostate VL - 76 UR - https://doi.org/10.1002/pros.23180 DO - 10.1002/pros.23180 ID - Sartor2016 ER - TY - BOOK AU - Sæterdal, I. PY - 2016 DA - 2016// TI - Health technology assessment of the new drugs for patients with metastatic castration resistant prostate cancer. Report from Kunnskapssenteret PB - Norwegian Knowledge Centre for the Health Services CY - Oslo ID - Sæterdal2016 ER - TY - JOUR AU - Schnell-Inderst, P. PY - 2015 DA - 2015// TI - Health technology assessment of medical devices: what is different? An overview of three European projects JO - The Journal of Evidence and Quality in Health Care VL - 109 ID - Schnell-Inderst2015 ER - TY - BOOK AU - Schöffski, O. AU - Schulenburg, J. M. PY - 2012 DA - 2012// TI - Gesundheitsökonomische Evaluationen PB - Springer CY - Berlin UR - https://doi.org/10.1007/978-3-642-21700-5 DO - 10.1007/978-3-642-21700-5 ID - Schöffski2012 ER - TY - STD TI - Szczygieł N, Rutkowska-Podołowska M, Michalski G. Information and Communication Technologies in Healthcare: Still Innovation or Reality? Innovative and Entrepreneurial Value-creating Approach in Healthcare Management. 5th Central European Conference in Regional Science 2014, Technical University of Košice, 1020–1029. ID - ref38 ER - TY - JOUR AU - Stevens, A. AU - Milne, R. AU - Burls, A. PY - 2003 DA - 2003// TI - Health technology assessment: history and demand (2003) JO - J Public Health Med VL - 25 UR - https://doi.org/10.1093/pubmed/fdg022 DO - 10.1093/pubmed/fdg022 ID - Stevens2003 ER - TY - JOUR AU - Toumi, M. o. n. d. h. e. r. AU - Rémuzat, C. é. c. i. l. e. PY - 2016 DA - 2016// TI - Value added medicines: what value repurposed medicines might bring to society? JO - Journal of Market Access & Health Policy VL - 5 UR - https://doi.org/10.1080/20016689.2017.1264717 DO - 10.1080/20016689.2017.1264717 ID - Toumi2016 ER - TY - BOOK PY - 1991 DA - 1991// TI - Assessing the effects of health technologies PB - Department of Health CY - London ID - ref41 ER - TY - STD TI - US Congress, Office of Technology Assessment. Technology Assessment in Business and Government. Summary and Analysis. Washington, DC: US Government Printing Office; 1977. http://govinfo.library.unt.edu/ota/Ota_5/DATA/1977/7711.PDF. UR - http://govinfo.library.unt.edu/ota/Ota_5/DATA/1977/7711.PDF ID - ref42 ER - TY - STD TI - US Congress, Office of Technology Assessment, Health Care Technology and Its Assessment in Eight Countries, OTA-BP-H-140 (Washington, DC: U.S. Government Printing Office, February 1995). http://ota.fas.org/reports/9562.pdf. UR - http://ota.fas.org/reports/9562.pdf ID - ref43 ER - TY - STD TI - Xofigo: Súhrn charakteristických vlastností lieku. https://ec.europa.eu/health/documents/community-register/2013/20131113126978/anx_126978_sk.pdf. Accessed 10 Jan 2018. UR - https://ec.europa.eu/health/documents/community-register/2013/20131113126978/anx_126978_sk.pdf ID - ref44 ER - TY - JOUR AU - Zavadil, M. AU - Rogalewicz, V. AU - Kubátová, I. AU - Matloňová, V. AU - Salačová, K. PY - 2016 DA - 2016// TI - Hodnocení zdravotnických technologií na úrovni nemocnice JO - Časopis lékařů českých VL - 155 ID - Zavadil2016 ER -